The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells

Johnson, A. J., Yeh, Y. Y., Smith, L. L., Wagner, A. J., Hessler, J., Gupta, S., … Byrd, J. C. (2012, December). The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells. Leukemia. https://doi.org/10.1038/leu.2012.144